JMIR Publications

Journal of Medical Internet Research

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 02.05.14 in Vol 16, No 5 (2014): May

This paper is in the following e-collection/theme issue:

Works citing "Monitoring of Internet Forums to Evaluate Reactions to the Introduction of Reformulated OxyContin to Deter Abuse"

According to Crossref, the following articles are citing this article (DOI 10.2196/jmir.3397):

(note that this is only a small subset of citations)

  1. Gasior M, Bond M, Malamut R. Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations. Postgraduate Medicine 2016;128(1):85
    CrossRef
  2. Jones MR, Carney MJ, Kaye RJ, Prabhakar A, Kaye AD. Drug Formulation Advances in Extended-Release Medications for Pain Control. Current Pain and Headache Reports 2016;20(6)
    CrossRef
  3. Sarker A, O’Connor K, Ginn R, Scotch M, Smith K, Malone D, Gonzalez G. Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter. Drug Safety 2016;39(3):231
    CrossRef
  4. Maincent J, Zhang F. Recent advances in abuse-deterrent technologies for the delivery of opioids. International Journal of Pharmaceutics 2016;510(1):57
    CrossRef
  5. Coplan P, Chilcoat H, Butler S, Sellers E, Kadakia A, Harikrishnan V, Haddox J, Dart R. The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting. Clinical Pharmacology & Therapeutics 2016;100(3):275
    CrossRef
  6. Gudin J, Levy-Cooperman N, Kopecky EA, Fleming AB. Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Abuse-Deterrent Properties. Pain Medicine 2015;16(11):2142
    CrossRef
  7. Peacock A, Degenhardt L, Hordern A, Larance B, Cama E, White N, Kihas I, Bruno R. Methods and predictors of tampering with a tamper-resistant controlled-release oxycodone formulation. International Journal of Drug Policy 2015;26(12):1265
    CrossRef
  8. R. Scott K, Nelson L, Meisel Z, Perrone J. Opportunities for Exploring and Reducing Prescription Drug Abuse Through Social Media. Journal of Addictive Diseases 2015;34(2-3):178
    CrossRef
  9. Sellers EM, Shram MJ, Schoedel KA. The US FDA Draft Guidance for Developing Abuse-Deterrent Opioid Analgesics: 2014 and Beyond. Pharmaceutical Medicine 2014;28(6):317
    CrossRef